𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neoadjuvant therapy for pancreatic cancer: A current review

✍ Scribed by Daniel E. Abbott; Marshall S. Baker; Mark S. Talamonti


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
219 KB
Volume
101
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Neoadjuvant therapy for pancreatic cance
✍ J. Kleeff; H. Friess; M. W. BΓΌchler πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 54 KB πŸ‘ 1 views
Adjuvant therapy for pancreatic cancer :
✍ Dan S. Zuckerman; David P. Ryan πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 98 KB

## Abstract Pancreatic cancer is uniformly fatal unless it can be surgically resected. Survival rates for the 15% to 20% of patients who have resectable disease, however, are a disappointing 10% to 30%, depending on the status of margins and surrounding lymph nodes. In the mid‐1980s, a landmark stu

Neoadjuvant therapy for breast cancer
✍ Stephen V. Liu; Laleh Melstrom; Kathy Yao; Christy A. Russell; Stephen F. Sener πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 116 KB
Neoadjuvant therapy for oesophagogastric
✍ F. Lordick; H. J. Stein; C. Peschel; J. R. Siewert πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 155 KB πŸ‘ 1 views
Gene therapy for pancreatic cancer
✍ Shin Takeda; Akimasa Nakao; Koji Miyoshi; Hiroshi Takagi πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 36 KB πŸ‘ 2 views

It has been approximately 7 years since the introduction of gene therapy. Since conventional procedures such as surgery, chemotherapy, and radiotherapy have had limited therapeutic value for cancer patients, the evolution of gene therapy seems a promising alternative to many researchers and clinicia